January 6, 2023
Shionogi said on January 4 that its oral COVID-19 treatment Xocova (ensitrelvir) has been filed in South Korea through its local partner Ildong Pharmaceutical. The drug’s new drug application for conditional approval has been accepted for review by the Ministry...read more